Article Text

Download PDFPDF
Does the measurement of fractional exhaled nitric oxide help asthma management?

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

In the search for an objective measure or biomarker of asthma control, fractional exhaled nitric oxide (FeNO) has looked a promising candidate. However, the benefit of using FeNO in addition to symptom-guided treatment is not clear. Turner S et al (Lancet Respiratory Medicine 2022;10:584–92 have successfully conducted and adequately powered study to evaluate the efficacy of adding FeNO to symptom-guided treatment in children with asthma vs only symptom-guided treatment. This is the first randomised clinical trial (RCT) to examine whether the addition of FeNO to symptom-guided treatment reduces asthma exacerbations in children. The RAACENO study was a multicentre, …

View Full Text


  • Provenance and peer review Commissioned; internally peer reviewed.